Apriori Bio, A*STAR IDL Partner to Develop Next-Gen AI-Designed saRNA Flu Vaccines
Apriori Bio, a Flagship Pioneering company focused on creating variant-resilient vaccines, has announced a strategic research partnership with the ASTAR Infectious Diseases Labs (ASTAR IDL) to co-develop next-generation self-amplifying RNA (saRNA) vaccines for seasonal and pandemic influenza.
Manufacturing | 19/11/2025 | By Darshana
Rockwell Automation Expanding US Footprint with New Greenfield Manufacturing Site
Rockwell Automation to build new greenfield manufacturing site in Southeastern Wisconsin as part of its USD 2 billion investment plan to strengthen US manufacturing and digital capability.
Manufacturing | 19/11/2025 | By Dineshwori
BPL Partners with ALPINION to Launch Next-Gen X CUBE 50 Ultrasound in India
BPL Medical Technologies, one of India’s leading medical equipment brands with a 50-year legacy, has partnered with ALPINION Medical Systems to introduce the X CUBE 50 ultrasound system from Korea to the Indian market.
Manufacturing | 18/11/2025 | By Darshana
Esaote and Schiller Americas Partner to Expand Advanced Cardiac Imaging Solutions in the US
Esaote, a global leader in medical imaging, has announced a strategic partnership with Schiller Americas, a major provider of cardiopulmonary diagnostic solutions. The collaboration aims to strengthen both companies’ presence in the cardiovascular imaging market and expand access to Esaote’s advanced ultrasound technologies across the United States.
Manufacturing | 17/11/2025 | By Darshana
Novartis Opens New Radioligand Therapy Plant in California under USD 23 Billion US Expansion Plan
Novartis has inaugurated its third US-based radioligand therapy (RLT) manufacturing facility in Carlsbad, California, expanding its production network to meet growing demand and maintain a 99.9 percent on-time delivery rate for patients across the western United States, Alaska, and Hawaii.
Manufacturing | 12/11/2025 | By Dineshwori
Primrose Bio Launches Next-Gen RNA Polymerase for Self-Amplifying mRNA
Primrose Bio has introduced Prima RNApols ExTend Cap AU, an advanced RNA polymerase designed to enhance capping efficiency and reduce double-stranded RNA formation in the production of self-amplifying mRNA, improving yield and quality in mRNA manufacturing.
Manufacturing | 12/11/2025 | By Dineshwori
Novartis Opens New California Plant to Boost Cancer Drug Production
Novartis has opened a new 10,000-square-foot manufacturing facility in Carlsbad, California, to produce advanced radioligand therapies (RLTs) for cancer treatment. These innovative therapies combine precision targeting with radioactive particles to attack cancer cells while minimizing damage to healthy tissue.
Manufacturing | 11/11/2025 | By Darshana
Eli Lilly to Pour USD 1.2B into Puerto Rico Facility Expansion Amid USA Manufacturing Push
Eli Lilly announced plans to invest more than USD 1.2 billion to expand and modernise its Lilly del Caribe manufacturing site in Carolina, Puerto Rico, as part of its broader initiative to enhance pharmaceutical production in the United States.
Manufacturing | 03/11/2025 | By Darshana | 114
Codexis and Nitto Denko Avecia Partner to Advance Enzymatic Oligonucleotide Manufacturing
Under the agreement, Nitto Denko Avecia will evaluate Codexis’ ECO Synthesis™ Manufacturing Platform, an enzyme-catalysed alternative to traditional solid-phase oligonucleotide synthesis.
Manufacturing | 01/11/2025 | By Darshana | 168
Ajinomoto Bio-Pharma and Olon Forge Partnership to Advance Sustainable Biologics Manufacturing
Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a global leader in biopharmaceutical contract development and manufacturing, has entered into a strategic partnership with Olon S.p.A. to provide innovative, large-scale drug substance manufacturing solutions for pharmaceutical and biotechnology clients.
Manufacturing | 30/10/2025 | By Darshana | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy